Ivy Cosmetics Corporation AI Stock Analysis
Want to see JP:4918 full AI Analyst Report?
Ivy Cosmetics Corporation (4918) AI Stock Analysis
Ivy Cosmetics Corporation
(TSE/TYO:4918)
Ivy Cosmetics is anchored by exceptional financial stability, massive deleveraging (D/E ratio of 0.10), and strong cash flow generation, making it a highly resilient enterprise. The stock offers attractive value with a P/E of 15.51 and a 2.90% dividend yield. While recent technical momentum is powerfully bullish, an RSI exceeding 90 signals heavily overbought conditions that could prompt short-term price pullbacks. The most significant ongoing risk remains the company's persistent decline in annual revenue, which limits its broader growth trajectory despite recovering profit margins.
Ivy Cosmetics Corporation (4918) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 3.14B
- Dividend Yield
- 2.99%
- Average Volume (3M)
- 45.46K
- Price to Earnings (P/E)
- 14.8
- Beta (1Y)
- 1.20
- Revenue Growth
- -5.54%
- EPS Growth
- -55.93%
- Country
- Japan
- Employees
- 179
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Household & Personal Products
Ivy Cosmetics Corporation Business Overview & Revenue Model
Company Description
Ivy Cosmetics Corporation manufactures and distributes a comprehensive array of cosmetic products and beauty-enhancing supplements. Their extensive catalog includes fundamental skincare items like deep-penetrating beauty liquids, various lotions, emu...
Ivy Cosmetics Corporation Financial Statement Overview
Summary
Exceptional financial stability driven by an ironclad balance sheet, massive deleveraging, and robust free cash flow generation, though partially offset by persistent top-line revenue contraction.
Income Statement
55NeutralBalance Sheet
85Very PositiveCash Flow
88Very Positive| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.64B | 2.93B | 2.71B | 2.94B | 3.53B |
| Gross Profit | 1.84B | 2.07B | 1.91B | 2.11B | 2.42B |
| EBITDA | 236.31M | 20.62M | 242.60M | -33.16M | 185.13M |
| Net Income | 164.53M | 43.01M | 160.31M | -384.61M | 40.38M |
Balance Sheet | |||||
| Total Assets | 3.64B | 3.57B | 3.57B | 3.85B | 4.49B |
| Cash, Cash Equivalents and Short-Term Investments | 1.04B | 577.94M | 208.73M | 247.67M | 129.38M |
| Total Debt | 278.01M | 211.34M | 451.69M | 1.05B | 1.18B |
| Total Liabilities | 1.00B | 1.10B | 1.33B | 1.87B | 2.22B |
| Stockholders Equity | 2.64B | 2.47B | 2.24B | 1.98B | 2.27B |
Cash Flow | |||||
| Free Cash Flow | 385.37M | 424.68M | 408.70M | 243.33M | -160.58M |
| Operating Cash Flow | 451.04M | 445.94M | 453.06M | 278.59M | -107.06M |
| Investing Cash Flow | -58.15M | -18.43M | 7.30M | -29.30M | 63.30M |
| Financing Cash Flow | 70.61M | -58.27M | -499.31M | -131.00M | 59.71M |
Ivy Cosmetics Corporation Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4918, the sentiment is Positive. The current price of 502.00 is above the 20-day moving average (MA) of 356.50, above the 50-day MA of 323.66, and above the 200-day MA of 324.67, indicating a bullish trend. The MACD of 50.42 indicates Negative momentum. The RSI at 84.36 is Negative, neither overbought nor oversold. The STOCH value of 95.78 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4918.
Ivy Cosmetics Corporation Peers Comparison
Overall Rating
JP:491877Outperform
JP:492668Neutral
JP:492567Neutral
JP:493462Neutral
JP:492956Neutral
JP:492055Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | JPY 2.85B | 14.82 | ― | 2.99% | -5.54% | -55.93% | |
| 68Neutral | JPY 5.34B | 20.94 | ― | 1.60% | 1.51% | -18.54% | |
| 67Neutral | JPY 6.25B | 10.83 | ― | 2.42% | -2.92% | -25.96% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 62Neutral | JPY 4.52B | 12.24 | ― | ― | -14.09% | -22.72% | |
| 56Neutral | JPY 5.89B | 36.88 | ― | 1.64% | -1.71% | 314.83% | |
| 55Neutral | JPY 2.24B | 8.25 | ― | 2.81% | 9.96% | 2053.18% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4918 | Ivy Cosmetics Corporation | 502.00 | 187.02 | 59.38% | |
| JP:4920 | Nippon Shikizai, Inc. | 1067.00 | 5.78 | 0.54% | |
| JP:4925 | HABA Laboratories, Inc. | 1653.00 | 11.31 | 0.69% | |
| JP:4926 | C'BON COSMETICS Co., Ltd. | 1247.00 | 66.39 | 5.62% | |
| JP:4929 | ADJUVANT HOLDINGS CO., LTD. | 733.00 | -14.87 | -1.99% | |
| JP:4934 | Premier Anti-Aging Co., Ltd. | 518.00 | -181.00 | -25.89% |
Ivy Cosmetics Corporation Corporate Events
Ivy Cosmetics Reports September 2026 Sales and Profit Growth
The release identifies Ivy Cosmetics Corporation as a general-business company listed on Tokyo’s stock exchanges, but does not specify its industry, primary products or services, or market focus.For the September 2026 reporting period, net sales rose...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 18, 2026
